Susquehanna International Group’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.42M Buy
75,258
+51,590
+218% +$1.91M ﹤0.01% 5728
2025
Q4
$996K Sell
23,668
-2,337
-9% -$94.2K ﹤0.01% 7204
2025
Q3
$893K Sell
26,005
-582,840
-96% -$16.7M ﹤0.01% 7608
2025
Q2
$16.5M Buy
608,845
+72,441
+14% +$2.1M ﹤0.01% 2217
2025
Q1
$15.9M Buy
536,404
+487,614
+999% +$18.6M ﹤0.01% 1968
2024
Q4
$1.93M Buy
48,790
+18,930
+63% +$717K ﹤0.01% 5387
2024
Q3
$1.02M Sell
29,860
-99,092
-77% -$2.79M ﹤0.01% 6746
2024
Q2
$2.79M Buy
128,952
+98,688
+326% +$2.07M ﹤0.01% 4448
2024
Q1
$671K Sell
30,264
-94,457
-76% -$2.3M ﹤0.01% 7796
2023
Q4
$3.43M Buy
124,721
+84,657
+211% +$2.04M ﹤0.01% 4350
2023
Q3
$895K Buy
40,064
+9,021
+29% +$232K ﹤0.01% 6881
2023
Q2
$791K Sell
31,043
-87,067
-74% -$2.11M ﹤0.01% 7224
2023
Q1
$2.63M Buy
118,110
+11,207
+10% +$271K ﹤0.01% 4581
2022
Q4
$2.54M Sell
106,903
-37,706
-26% -$876K ﹤0.01% 4291
2022
Q3
$2.4M Buy
144,609
+108,215
+297% +$2.44M ﹤0.01% 4562
2022
Q2
$724K Sell
36,394
-27,766
-43% -$561K ﹤0.01% 7336
2022
Q1
$1.77M Sell
64,160
-14,310
-18% -$409K ﹤0.01% 5753
2021
Q4
$3.23M Buy
78,470
+23,334
+42% +$1.03M ﹤0.01% 4515
2021
Q3
$2.56M Buy
55,136
+6,839
+14% +$298K ﹤0.01% 5293
2021
Q2
$1.93M Sell
48,297
-12,024
-20% -$514K ﹤0.01% 5996
2021
Q1
$3.24M Sell
60,321
-35,053
-37% -$2.02M ﹤0.01% 4787
2020
Q4
$4.67M Buy
95,374
+54,333
+132% +$2.52M ﹤0.01% 3511
2020
Q3
$1.33M Buy
41,041
+17,435
+74% +$554K ﹤0.01% 5430
2020
Q2
$611K Sell
23,606
-25,864
-52% -$644K ﹤0.01% 6943
2020
Q1
$1.2M Sell
49,470
-15,384
-24% -$387K ﹤0.01% 4961
2019
Q4
$1.81M Sell
64,854
-8,988
-12% -$233K ﹤0.01% 4489
2019
Q3
$1.77M Sell
73,842
-2,161
-3% -$57.5K ﹤0.01% 4457
2019
Q2
$2.17M Buy
+76,003
New +$1.9M ﹤0.01% 4021
2019
Q1
Sell
-15,946
Closed -$305K 9901
2018
Q4
$201K Buy
+15,946
New +$189K ﹤0.01% 7743
2018
Q2
Sell
-14,554
Closed -$81K 10485
2018
Q1
$81K Buy
+14,554
New +$90.1K ﹤0.01% 8784
2017
Q4
Sell
-39,293
Closed -$292K 9947
2017
Q3
$345K Buy
39,293
+19,407
+98% +$158K ﹤0.01% 7157
2017
Q2
$166K Sell
19,886
-30,951
-61% -$252K ﹤0.01% 8437
2017
Q1
$467K Sell
50,837
-48,792
-49% -$399K ﹤0.01% 6593
2016
Q4
$771K Buy
99,629
+76,136
+324% +$569K ﹤0.01% 6071
2016
Q3
$179K Sell
23,493
-12,214
-34% -$69.1K ﹤0.01% 7662
2016
Q2
$180K Sell
35,707
-6,437
-15% -$34.5K ﹤0.01% 7685
2016
Q1
$228K Buy
+42,144
New +$249K ﹤0.01% 7757

Other funds holding VCYT

Susquehanna International Group's VCYT Position: Q1 2026 in Review

Susquehanna International Group increased its Veracyte (VCYT) stake by 218% in Q1 2026, buying an estimated $1.91M and bringing the position to 75,258 shares worth $2.42M. The position accounts for ﹤0.01% of the portfolio, ranked #5728.

Susquehanna International Group first reported a position in VCYT in Q1 2016 and has held it in 37 quarters since. The position peaked at $16.5M in Q2 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Susquehanna International Group held 75,258 shares of Veracyte worth $2.42M as of Q1 2026.
  • Susquehanna International Group bought 51,590 Veracyte shares in Q1 2026, an estimated $1.91M.
  • Veracyte made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5728 holding.
  • Susquehanna International Group first reported a position in Veracyte in Q1 2016 and has held it in 37 quarters since.
  • Susquehanna International Group's Veracyte position peaked at $16.5M in Q2 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.